Results 51 to 60 of about 28,733 (232)
Brazilian Journal of Cardiovascular Surgery, 2016 Objective: Transcatheter aortic valve implantation has recently been used in the treatment of severe aortic valve stenosis, particularly in patients with high mortality and morbidity rates for open surgery.
Cemal Kocaaslan +7 more
doaj +1 more source
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background Transcatheter aortic valve implantation (TAVI) in bicuspid aortic valve (BAV) anatomy remains challenging due to anatomical complexity and limited trial data. New‐generation balloon‐expandable valves, such as Myval, require further evaluation in this subgroup.
Balázs Magyari +11 more
wiley +1 more source
, 2012 Background: Valvular aortic stenosis is a common disease in the elderly, often in multimorbid patients. It is often associated with coronary artery disease and peripheral artery disease.
Michel, Sebastian +6 more
core +1 more source
Transcatheter Aortic Valve Replacement and Stroke [PDF]
Circulation: Cardiovascular Interventions, 2015 The evaluation of any therapy includes an assessment of benefits and risks. For percutaneous coronary interventions, death and myocardial infarction are typically selected as the 2 hard end points for describing adverse events. Stroke may be observed during percutaneous coronary intervention and be a direct result of the procedure.
Neil J, Wimmer, David O, Williams
openaire +2 more sources
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Aortic stenosis (AS) is associated with a heightened burden of cardiovascular comorbidities, atrial fibrillation (AF), and progressive valvular calcification, all of which may contribute to cerebrovascular events across the disease continuum.
Priyanka Boettger +7 more
wiley +1 more source
Predicting mortality after transcatheter aortic valve replacement external validation of the Transcatheter Valve Therapy registry model [PDF]
, 2017 BACKGROUND: The Transcatheter Valve Therapy (TVT) registry model was recently developed to predict the risk of in-hospital mortality in patients undergoing transcatheter aortic valve replacement.
Oliver Muller +34 more
core +1 more source
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background The EMPIRE I study assessed the early (30 days) safety and efficacy of a new fully repositionable delivery system (IMPERIA) for the commercially available ALLEGRA transcatheter aortic valve in patients with either severe native aortic stenosis or a degenerated surgical bioprosthesis.
José Antonio Baz +15 more
wiley +1 more source
Sustained Improvement of Left Ventricular Strain following Transcatheter Aortic Valve Replacement
, 2019 PURPOSE: Left ventricular (LV) mechanics are impaired in patients with severe aortic stenosis (AS). Transcatheter aortic valve replacement (TAVR) has become a widespread technique for patients with severe AS considered inoperable or high risk for open ...
Echeverría García, T. +14 more
core +1 more source
Pathophysiologic Consequences of Early Coarctation Stenting in a Longitudinal Porcine Model
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background Novel stent technologies offer early intravascular treatment options for coarctation (COA). Mid‐to‐long‐term cardiovascular responses to early COA stent interventions are undefined. Aims We studied a porcine model of COA, with and without early stent implantation with serial dilation to adult aortic diameters, aiming to define ...
Leah M. Gober +7 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya +9 more
wiley +1 more source